Share on StockTwits

Immune Design Corp (NASDAQ:IMDZ) major shareholder Alta Partners Viii, L.P. acquired 299,559 shares of the stock on the open market in a transaction that occurred on Tuesday, July 29th. The shares were purchased at an average cost of $12.00 per share, with a total value of $3,594,708.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Immune Design Corp (NASDAQ:IMDZ) remained flat at $12.00 during trading on Thursday. 37,836 shares of the company’s stock traded hands. Immune Design Corp has a one year low of $11.51 and a one year high of $12.81. The stock’s 50-day moving average is $12. and its 200-day moving average is $12.. The company’s market cap is $189.2 million.

Immune Design Corp is a clinical-stage immunotherapy company. The Company has engineered its technologies to activate the immune system’s natural ability to create tumor-specific cytotoxic T cells (NASDAQ:IMDZ), to fight cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.